Recommendations for the use of LDL apheresis

This publication has 48 references indexed in Scilit:

• Cardiovascular Risk Reduction in High-Risk Pediatric Patients
  Circulation, 2006
• In Vitro Evaluation of Dextran Sulfate Cellulose Beads for Whole Blood Infusion Low‐Density Lipoprotein‐Hemoperfusion
  Therapeutic Apheresis, 2002
• Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia
  The American Journal of Cardiology, 1998
• Long-Term Effects of Low-Density Lipoprotein Apheresis Using an Automated Dextran Sulfate Cellulose Adsorption System fn1fn1This study was supported by a grant from the Kaneka America Corporation, New York, New York.
  The American Journal of Cardiology, 1998
• The HELP‐LDL‐apheresis multicentre study, an angiographically assessed trial on the role of LDL‐apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL‐cholesterol plasma concentrations and the course of coronary heart disease*
  European Journal of Clinical Investigation, 1994
• Cerebral blood flow velocity and systemic vascular resistance after acute reduction of low-density lipoprotein in familial hypercholesterolemia.
  Stroke, 1993
• Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens
  JAMA, 1990
• Selective removal of low density lipoproteins (LDL) by precipitation at low pH: First clinical application of the HELP system
  Journal of Molecular Medicine, 1987
• Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.
  Circulation, 1984
• PLASMA EXCHANGE IN THE MANAGEMENT OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLÆMIA
  The Lancet, 1975